|
1
|
Carling T and Udelsman R: Thyroid cancer.
Annu Rev Med. 65:125–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li X, Abdel-Mageed AB, Mondal D and Kandil
E: MicroRNA expression profiles in differentiated thyroid cancer, a
review. Int J Clin Exp Med. 6:74–80. 2013.PubMed/NCBI
|
|
3
|
Jang EK, Song DE, Sim SY, Kwon H, Choi YM,
Jeon MJ, Han JM, Kim WG, Kim TY, Shong YK and Kim WB: NRAS codon 61
mutation is associated with distant metastasis in patients with
follicular thyroid carcinoma. Thyroid. 24:1275–1281. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schlumberger MJ: Papillary and follicular
thyroid carcinoma. N Engl J Med. 338:297–306. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM,
Schlumberger M, et al: 2015 American Thyroid Association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The American Thyroid Association
guidelines task force on thyroid nodules and differentiated thyroid
cancer. Thyroid. 26:1–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin H, Sun Y, Wang SY and Cheng XD:
Matrine activates PTEN to induce growth inhibition and apoptosis in
V600EBRAF harboring melanoma cells. Int J Mol Sci. 14:16040–16057.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei YP, Wang XH, Liu G, Zhang JF, Yang YX,
Zhang J, Song XL, Li ZD and Zhao LD: Matrine exerts inhibitory
effects in melanoma through the regulation of miR-19b-3p/PTEN. Int
J Oncol. 53:791–800. 2018.PubMed/NCBI
|
|
8
|
Niu HY, Zhang YF, Wu BG, Zhang Y, Jiang HF
and He P: Matrine induces the apoptosis of lung cancer cells
through downregulation of inhibitor of apoptosis proteins and the
Akt signaling pathway. Oncol Rep. 32:1087–1093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
An Q, Han C, Zhou Y, Li F, Li D, Zhang X,
Yu Z, Duan Z and Kan Q: Matrine induces cell cycle arrest and
apoptosis with recovery of the expression of miR-126 in the A549
non-small cell lung cancer cell line. Mol Med Rep. 14:4042–4048.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang H, Du T, Xu G, Lai Y, Fan XX, Chen
X, Li WJ, Yue F, Li Q, Liu L and Li K: Matrine suppresses invasion
of castration-resistant prostate cancer cells by downregulating
MMP-2/9 via NF-κB signaling pathway. Int J Radiat Oncol.
50:640–648. 2017.
|
|
11
|
Zhao L, Zhang X and Cui S: Matrine
inhibits TPC-1 human thyroid cancer cells via the miR-21/PTEN/Akt
pathway. Oncol Lett. 16:2965–2970. 2018.PubMed/NCBI
|
|
12
|
Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang
HH, Liu X, Liang DS, Lu YJ, Shan HL and Jiang HC: Matrine inhibits
breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells.
Cell Physiol Biochem. 30:631–641. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tetik Vardarlı A, Düzgün Z, Erdem C,
Kaymaz BT, Eroglu Z and Çetintas VB: Matrine induced G0/G1 arrest
and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL)
cells. Bosn J Basic Med Sci. 18:141–149. 2018.PubMed/NCBI
|
|
14
|
Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K
and Yang GH: MicroRNA-21 (miR-21) represses tumor suppressor PTEN
and promotes growth and invasion in non-small cell lung cancer
(NSCLC). Clin Chim Acta. 411:846–852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moriyama T, Ohuchida K, Mizumoto K, Yu J,
Sato N, Nabae T, Takahata S, Toma H, Nagai E and Tanaka M:
MicroRNA-21 modulates biological functions of pancreatic cancer
cells including their proliferation, invasion, and chemoresistance.
Mol Cancer Ther. 8:1067–1074. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fragni M, Bonini SA, Bettinsoli P, Bodei
S, Generali D, Bottini A, Spano PF, Memo M and Sigala S: The
miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral
effects of zoledronic acid in human breast cancer cell lines.
Naunyn Schmiedebergs Arch Pharmacol. 389:529–538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Z, Wang J, Guo C and Fan X:
microRNA-21 mediates epithelial-mesenchymal transition of human
hepatocytes via PTEN/Akt pathway. Biomed Pharmacother. 69:24–28.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pfeffer SR, Yang CH and Pfeffer LM: The
Role of miR-21 in cancer. Drug Dev Res. 76:270–277. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Peng W, Tang T, Xia L, Wang XD,
Duan BF and Shu Y: MicroRNAs as promising biomarkers for
tumor-staging: Evaluation of MiR21 MiR155 MiR29a and MiR92a in
predicting tumor stage of rectal cancer. Asian Pac J Cancer Prev.
15:5175–5180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bleau AM, Hambardzumyan D, Ozawa T,
Fomchenko EI, Huse JT, Brennan CW and Holland EC: PTEN/PI3K/Akt
pathway regulates the side population phenotype and ABCG2 activity
in glioma tumor stem-like cells. Cell Stem Cell. 4:226–235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carnero A, Blanco-Aparicio C, Renner O,
Link W and Lea JF: The PTEN/PI3K/AKT signalling pathway in cancer,
therapeutic implications. Curr Cancer Drug Targets. 8:187–198.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Löffler D, Brocke-Heidrich K, Pfeifer G,
Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M,
Blumert C, Bauer K, et al: Interleukin-6 dependent survival of
multiple myeloma cells involves the Stat3-mediated induction of
microRNA-21 through a highly conserved enhancer. Blood.
110:1330–1333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang N, Han F, Cui H, Huang J, Wang T,
Zhou Y and Zhou J: Matrine suppresses proliferation and induces
apoptosis in human cholangiocarcinoma cells through suppression of
JAK2/STAT3 signaling. Pharmacol Rep. 67:388–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen SF, Zhang ZY and Zhang JL: Matrine
increases the inhibitory effects of afatinib on H1975 cells via the
IL-6/JAK1/STAT3 signaling pathway. Mol Med Rep. 16:2733–2739. 2017.
View Article : Google Scholar : PubMed/NCBI
|
